Related Experiment Video
Updated: Aug 21, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Differential diagnosis of tuberculous meningitis from partially-treated pyogenic meningitis by cell ELISA
Rajpal S Kashyap1, Rani P Kainthla, Ravindra M Satpute
1Biochemistry Research Laboratory, Central India Institute of Medical Sciences, 88/2 Bajaj Nagar, Nagpur-440010, India. raj_ciims@rediffmail.com <raj_ciims@rediffmail.com>
Background:
Tuberculous meningitis (TBM) is a major global health problem, and it is sometimes difficult to perform a differential diagnosis of this disease from other diseases, particularly partially-treated pyogenic meningitis (PTPM). In an earlier study, we demonstrated the presence of a 30-kD protein antigen in cerebrospinal fluid (CSF) of TBM patients. We have also shown that lymphocytes from CSF of TBM patients respond differently to this antigen than do those from PTPM patients. The purpose of this study was to develop an assay that can discriminate between TBM and PTPM.
Methods:
We developed a cell enzyme-linked immunosorbant assay (Cell ELISA) to quantitatively measure production of antibodies against the 30-kD protein in B cells from CSF of TBM and PTPM patients.
Results:
The cell ELISA yielded 92% (11/12) sensitivity and 92% (11/12) specificity for the differential diagnosis of TBM from PTPM.
Conclusion:
When induced with the 30-kD protein antigen, B cells derived from CSF of TBM patients respond to IgG production within 24 h while those derived from PTPM patients do not respond.
Insights
A new cell enzyme-linked immunosorbant assay (Cell ELISA) can differentiate tuberculous meningitis (TBM) from partially-treated pyogenic meningitis (PTPM). The assay detects specific B cell responses to a 30-kD protein antigen in cerebrospinal fluid (CSF).
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Tuberculous meningitis (TBM) poses diagnostic challenges, often confused with partially-treated pyogenic meningitis (PTPM).
- A specific 30-kD protein antigen in cerebrospinal fluid (CSF) and differential lymphocyte responses were previously identified in TBM patients.
Purpose of the Study:
- To develop a diagnostic assay for distinguishing between TBM and PTPM.
Main Methods:
- A cell enzyme-linked immunosorbant assay (Cell ELISA) was developed.
- This assay quantifies antibody production against the 30-kD protein by B cells from CSF.
Main Results:
- The Cell ELISA demonstrated 92% sensitivity and 92% specificity in differentiating TBM from PTPM.
- B cells from TBM patients produced IgG antibodies within 24 hours when stimulated with the 30-kD antigen.
Conclusions:
- CSF B cells from TBM patients exhibit a rapid IgG production response to the 30-kD antigen.
- CSF B cells from PTPM patients do not show this response, enabling differential diagnosis.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Bacterial Meningitis I: Introduction
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Bacterial Meningitis